Virological and biochemical response in patients with HBeAG-negative chronic hepatitis B treated with peginterferon alfa-2a (40KD) with or without lamivudine: Results of 4-year follow-up

被引：24

作者：

Marcellin, P. ^{[1
,2
]}

Piratvisuth, T. ^{[3
]}

Brunetto, M. ^{[4
]}

Bonino, F. ^{[5
,6
]}

Lau, G. K. K. ^{[7
]}

Farci, P. ^{[8
]}

Yurdaydin, C. ^{[9
]}

Wu, J. ^{[10
]}

Popescu, M. ^{[11
]}

机构：

[1] Hop Beaujon, Serv Hepatol, INSERM, U481, Clichy, France

[2] Hop Beaujon, Ctr Rech Claude Bernard Hepatite Virales, Clichy, France

[3] Prince Songkla Univ, Dept Internal Med, Songklanagarind Hosp, NKC Inst Gastroenterol & Hepatol, Hat Yai, Thailand

[4] Univ Pisana, Azienda Osped, UO Gastroenterol & Epatol, Pisa, Italy

[5] Univ Pisa, Pisa, Italy

[6] Policlin Milan, Sci Direct, Fdn IRCCS, Pisa, Italy

[7] Univ Hong Kong, Queen Mary Hosp, Dept Med, Hong Kong, Hong Kong, Peoples R China

[8] Univ Cagliari, Cagliari, Italy

[9] Ankara Univ, Fac Med, TR-06100 Ankara, Turkey

[10] Roche, Dee Why, Australia

[11] Roche, Basel, Switzerland

来源：

关键词：

D O I：

10.1016/S0168-8278(08)60105-1

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

103

引用

页码：S46 / S46

页数：1